![General practitioner Jean Louis Bensoussan, administers a dose of AstraZeneca Covid-19 vaccine to a patient, in Gragnague near Toulouse, southern France, on February 26, 2021. Private practitioners in France started vaccinating vulnerable patients between 50 and 64 at their medical offices on February 25, as part of a new stage in the country's Covid-19 vaccination campaign. / AFP / Fred SCHEIBER](https://thenational-the-national-prod.cdn.arcpublishing.com/resizer/v2/XKBKDVGDN3NBAHH3N7PVCJXFUA.jpg?smart=true&auth=7ae99cab7eb45abfc642d82d000f82288534225e8c1a3cada20eaed1c1a0ba53&width=400&height=225)
A doctor administers a dose of the Oxford-AstraZeneca vaccine to a patient in Gragnague, southern France. AFP
A doctor administers a dose of the Oxford-AstraZeneca vaccine to a patient in Gragnague, southern France. AFP
French data shows 75% of AstraZeneca doses are unused
Paris widens number of people for whom vaccine is available but still lags behind in doses administered